In this study, chitosan-alginate polyelectrolyte microparticles containing the antibiotic, vancomycin chloride were prepared using the ionotropic gelation (coacervation) technique. In vitro release and drug transport mechanisms were studied concerning the chitosan only and alginate only microparticles as a control group. Further, the effect of porosity on the drug transport mechanism was also studied for chitosan-alginate mixed particles produced by lyophilizing in contrast to the air-dried non-porous particles. According to the in vitro release data, alginate only and chitosan only microparticles showed burst release and prolonged release respectively. Chitosan-alginate lyophilized microparticles showed the best-controlled release of vancomycin with the average release of 22 μg per day for 14 days. Also, when increasing alginate concentration there was no increase in the release rate of vancomycin. The release data of all the microparticles were treated with Ritger-Peppas, Higuchi, Peppas-Sahlin, zero-order, and first-order kinetic models. The best fit was observed with Peppas-Sahlin model, indicating the drug transport mechanism was controlled by both Fickian diffusion and case II relaxations. Also, Fickian diffusion dominates the drug transport mechanism of all air-dried samples during the study period. However, the Fickian contribution was gradually reducing with time. Porosity significantly effects the drug transport mechanism as case II relaxation dominates after day 10 of the lyophilized microparticles.
Introduction
Microparticles (MPs) have been extensively studied for the past few decades as a targeted drug delivery device in tissue engineering applications. Targeted drug delivery leads therapeutic agents in a site specific manner to a particular cell type or tissue (Patri et al., 2005) . Generally, biocompatible and biodegradable polymers have been widely used for MPs preparation. The most commonly used biodegradable polymers, such as poly(L-lactide) (PLA) and poly(D, L-lactideco-glycolide) (PLGA), cause toxicological effects due to the presence of organic solvent in the formulation methods (Caetano et al., 2016) . Therefore, natural polymers such as chitosan and sodium alginate are widely used in drug delivery systems due to their relatively simple ionic cross-linking methods, as described in elsewhere (Anal and Stevens, 2005; Caetano et al., 2016; Gombotz and Wee, 1998; Liu et al., 1997; Mantripragada and Jayasuriya, 2016; Pasparakis and Bouropoulos, 2006) . Chitosan, a deacetylated form of chitin extracted from crustacean shells, is a linear polysaccharide, composed of N-acetyl glucosamine (free amino groups) and glucosamine linked in a β (1-4) manner.
The ratio between glucosamine/N-acetyl glucosamine is known as the degree of deacetylation (DD) (Di Martino et al., 2005; George and Abraham, 2006) . Chitosan is usually insoluble in aqueous solutions above pH 7 but, because of the protonation of the free amino groups in glucosamine, chitosan dissolves in dilute acid solutions (pH < 6). Alginate is also a linear polysaccharide extracted from brown algae, but unlike chitosan, it dissolves in aqueous solutions. It contains a varying amount of 1-4 linked α-L-guluronic and β-D-mannuronic acid residues (Gombotz and Wee, 1998; Pasparakis and Bouropoulos, 2006) . Moreover, alginate has the ability to form gels by reacting with divalent cations such as Ca 2 + , Sr 2 + , and Ba 2 + under an extremely mild environment (George and Abraham, 2006 ). There are two major types of bone infections namely osteomyelitis and septic arthritis. The main reasons for these types of bone infections are open fractures due to high energy trauma (e.g., Gunshot wound, motor vehicle accidents) and joint arthroplasty (Cevher et al., 2006) . Most commonly, these types of bone infections are caused by staphylococci, a Gram-positive organism. Vancomycin, a broad spectrum glycopeptide antibiotic, is active against Gram-positive organisms. In previous studies, vancomycin encapsulated MPs were successfully used against Staphylococcus aureus (Cevher et al., 2006) and Staphylococcus epidermidis (Mantripragada and Jayasuriya, 2016) . According to Liu et al. (Liu et al., 2006) , microencapsulation is defined as a method of storing solid, liquid, or gaseous substances in miniature, sealed capsules that can release their contents at controlled rates under specific conditions. The main advantage of the biodegradable drug delivery system is that it will eliminate the need for additional surgery to remove the drug carrier. Also, the targeted drug delivery system uses a significantly less amount of drugs, as it reduces the side effects and improves the efficiency due to the localized release (Gbureck et al., 2008) .
The drug release from polymer particulate system involves three different mechanisms: (i) release due to polymer erosion, (ii) diffusion through the swollen matrix, and (iii) release from the surface of particles (Agnihotri et al., 2004; Fredenberg et al., 2011) . The schematic diagram of three mechanisms is shown in Fig. 1 . In most of the situations, drug release is driven by more than one mechanism. The release from the surface of the particle leads to burst release effect and drugs entrapped in the surface layer also follows this effect. This burst release can be avoided by washing MPs with water of proper solvent after crosslinking process, or by increasing the crosslinking density. However, these methods reduce the encapsulation efficiency of the drug (Agnihotri et al., 2004) . Apart from the previously described three mechanisms, the chemically controlled drug release mechanism is also possible in polymer hydrogel system. In this type of situation, drug (or molecules) release is determined by the chemical reactions occurring between the polymer network and releasable drug (Lin and Metters, 2006) . The knowledge of release kinetics is essential for the efficient use of the drug delivery system. The release of drug from delivery systems depends on many physical and chemical properties of both drug and the carrier, such as porosity, surface roughness, chemical composition, molecular weight, degradation rate, particle size, the amount of the pharmaceutical dosage form, and drug-matrix interaction (Costa and Lobo, 2001; Gbureck et al., 2008) .
Most commonly used kinetic model in drug release studies is the Ritger-Peppas model (Ritger and Peppas, 1987a ) (also known as power law). This model has been successfully used by numerous researchers for past few decades to describe the drug transport through Fickian diffusion and anomalous transport (Gbureck et al., 2008; Huang and Brazel, 2001; Li et al., 2008; Pasparakis and Bouropoulos, 2006; Raval et al., 2011; Serra et al., 2006; Shi et al., 2011; Siepmann and Peppas, 2001) . Apart from this model, Higuchi model (Carbinatto et al., 2014; Raval et al., 2011; Serra et al., 2006) , zero order model Liu et al., 2006; Serra et al., 2006; Yao and Weiyuan, 2010) , first order model (Borges et al., 2006; Carbinatto et al., 2014; Yan et al., 2017) , and Peppas-Sahlin model (Liu et al., 2006; Serra et al., 2006; Siepmann and Peppas, 2001; Yao and Weiyuan, 2010) were successfully used to describe the drug release mechanisms from polymer particulate systems.
The primary objective of this research work is to develop an injectable drug delivery system for the controlled release of vancomycin and study the drug transport mechanism of that system. According to the preliminary studies, we found that vancomycin release from chitosan MPs was relatively low and not suitable for drug delivery system. Also, alginate MPs showed burst release of vancomycin. So, we tried to combine those low and high drug release of low molecular weight (MW) chitosan and alginate MPs respectively by making chitosan-alginate mixed MPs. Even though these type of MPs were studied for the decades, very few studies have been conducted on drug transport mechanisms. Therefore, we examined the drug release mechanism of chitosan-alginate mixed MPs with respective to the chitosan alone and alginate alone MPs. Also, we were interested in elucidating the effect of European Journal of Pharmaceutical Sciences 114 (2018) 199-209 porosity on drug delivery mechanism.
Materials and methods

Materials
Low MW chitosan (MW: 50,000-190,000 kDa), sodium alginate, acetic acid (99.7%), and sodium tripolyphosphate (TPP) were purchased from Sigma Aldrich (St. Louis, MO)·Calcium chloride anhydrate was obtained from Fisher Scientific, USA, and phosphate buffered saline (PBS) was purchased from Gibco, Life Technologies, USA. Medical grade vancomycin hydrochloride was obtained from Mylan Institutional LLC, USA.
Fabrication of vancomycin encapsulated MPs
Coacervation method was used to prepare the MPs. Five types of MPs were prepared to observe the release mechanism of the vancomycin antibiotic. 20 ml of 2% (w/v) chitosan solution was prepared by dissolving low MW chitosan in 2% (v/v) acetic acid. The solution was filtered through nylon mesh with 52 μm pores, and 160 mg of vancomycin (8 mg/ml concentration) was added to the solution. The vancomycin concentration was obtained by the previous study conducted in our lab (Mantripragada and Jayasuriya, 2016) . After drug was completely dissolved, the chitosan solution was added dropwise to the TPP solution while under continuous stirring at 300 rpm for 2 h, and then particles were filtered and air-dried overnight at room temperature (this sample was indicated as CS). 5% (w/v) alginate solution was prepared by dissolving sodium alginate in deionized (DI) water from Milli-Q water system. Same amount of drug was added to the solution, and alginate solution was added dropwise to the 2% (w/v) calcium chloride solution while continuous stirring at 300 rpm for 2 h (this sample was indicated as AL).
Chitosan-alginate MPs were also prepared using coacervation method. 2%w/v chitosan and 2% (w/v) calcium chloride were dissolved in 20 ml of 2% (v/v) acetic acid solution. 160 mg of vancomycin (8 mg/ml) was added to the filtered chitosan/calcium chloride solution, and then the solution was added dropwise to the 1%w/v alginate and 1% (w/v) TPP solution. The system was kept under continuous stirring at 300 rpm for 45 min, and particles were air-dried overnight at room temperature (this sample was indicated as CS-1%AL). To observe the effect of porosity, another set of the sample with same concentrations was lyophilized overnight using Labconco FreeZone 4.5 (this sample was indicated as CS-1%AL LP). To observe the effect of increasing alginate concentration, another set of particles were prepared by changing the alginate concentration to 2% (w/v) in the crosslinking solution and particles were air-dried overnight (this sample was indicated as CS-2%AL).
Morphological analysis
The surface morphology of the five types of MPs was analyzed using Scanning electron microscope (SEM) (FEI Quanta 3D FEG, Environmental SEM). Morphological differences between the lyophilized and air-dried MPs were observed, using cross section of the Chitosan-alginate polyelectrolyte MPs.
Fourier transform infrared (FTIR) analysis
FTIR spectrums of the five types of MPs were taken at room temperature using FTIR spectrometer (FTS 4000, Excalibur series, Varian). Dried particles were crushed and mixed with potassium bromide (KBr). Then KBr pellets were formed using KBr kit and samples were analyzed at a resolution of 8 cm − 1 , average 100 scans from 4000 to 400 cm − 1 .
Swelling studies
The swelling test of the MPs was conducted in PBS (pH 7.4). 20 mg of MPs were placed in a glass vial containing 2 ml of PBS and kept it at 37°C under continuous shaking (150 rpm). The swollen particles were periodically removed and immediately weighed the wet weight by eliminating excess water with a blotting paper. The percentage swelling of the particles was calculated from the following formula:
where W s is the weight of the swollen particles, and W i is the initial weight of the particles. One-way Analysis of variance (ANOVA) was performed using IBM SPSS statistical software for this study to determine the statistical difference. Post hoc Turkey's test was performed to find the statistical difference between groups and probability value of p < 0.05 was used to determine the significance.
Determination of encapsulation efficiency% and loading degree%
The vancomycin loaded microparticles were crushed (except alginate MPs) and dissolved in 2% (v/v) acetic acid solution. After completely dissolving the powder, the absorbance of the supernatant was measured using UV-Vis Spectrophotometer (Jasco V-770) at 270 nm (Mantripragada and Jayasuriya, 2016; Buzia et al., 2015; Cevher et al., 2006; Shang et al., 2014) . 2% (v/v) acetic acid solution was used as a background sample. Alginate MPs were completely dissolved in 1 N NaOH solution and the same procedure was used to measure the absorbance using the 1 N NaOH as a background sample. Encapsulation efficiency (EE) was calculated from the formula;
Loading degree (LD) was also calculated from the following formula;
Amount of encapsulated vancomycin weight (mg) Total weight of vancomycin MPs (mg) 100
2.7. In vitro release of vancomycin 20 mg of vancomycin encapsulated MPs were suspended in 2 ml of PBS (pH 7.4) in a glass vial. The glass vials were incubated at 37°C with continuous rotation (Innova 2000 shaker) at 150 rpm for three weeks. PBS in the glass vials were collected at the predetermined time intervals and the release drug amounts were quantified spectrophotometrically (Alvarez-Lorenzo et al., 2005) by measuring the absorbance of the PBS at 270 nm using UV-Vis Spectrophotometer (Jasco V-770). At every time point, after taking PBS samples (2 ml) from the glass vials with MPs, new PBS was added to glass vials with MPs in order to maintain the sink conditions.
Release kinetic models
To study the vancomycin release mechanism from the different type of MPs, five different kinetic models were considered to fit the experimental data. Model 1 is given by the Ritger-Peppas equation (Ritger and Peppas, 1987a ):
where, M t and M inf are the cumulative drug release at time t and infinite time, respectively; k 1 is a constant which depends on the structural and geometrical characteristic of the particles, t is the release time and n is the diffusional exponent which indicates the drug release mechanism. For spherical delivery system, when n = 0.43, the drug release mechanism is the Fickian diffusion. When n = 0.85, drug release mechanism is completely Case II transport. When value of n is between 0.43 and 0.85, anomalous transport is observed (Ritger and Peppas, 1987b) .
Model 2 is Higuchi model. Although this model is frequently used to describe the drug transport mechanism of thin film hydrogels, this model also can be used to analyze the transport mechanism of spherical hydrogel systems.
where, k H is a kinetic constant and t is the release time. Model 3 is based on Peppas-Sahlin equation (Peppas and Sahlin, 1989 ),
where,k 1 , and k 2 are kinetic constants and m is the diffusional exponent. Model 4 is based on the zero order drug delivery (Costa and Lobo, 2001) and is expressed when n = 1 in Ritger-Peppas equation
k 0 is a kinetic constant. Finally, model 5 represents first order drug delivery, and it is expressed by the following equation;
where; a and b are the first order rate constants. All the above mathematical models are only valid for first 60% of the drug release from the MPs. Experimental data were analyzed by nonlinear least regression, using Origin Pro 9 software. Residual sum of the squares (RSS) was obtained to find out the best fit model. The minimal value of RSS is the best fit model to the experimental data (Serra et al., 2006) . Nevertheless, since a total number of parameters in equation effect to the RSS value, it was necessary to use a discriminatory criterion which was independent of the number of parameters in the each model. Therefore, Akaike Information Criterion (AIC) was used as given below (Yamaoka et al., 1978) 
where N is the number of experimental data points, p is the number of parameters in an estimated model, and RSS is the residual sum of squares. The model with the smallest AIC value is regarded as the best fit model to the drug release mechanism (Costa and Lobo, 2001; Serra et al., 2006) .
Results and discussion
Particles size and morphological analysis
Particles size of the MPs was measured using Vernier caliper and those values were further confirmed with SEM. Both dry state and wet state particle size were measured and average diameter and standard deviation (SD) are given in Table 1 . According to the SEM micrographs presented in Fig. 3 , MPs were spherical and the mean particle size diameter ranged from 550 to 700 μm except for lyophilized and alginate samples, which had a mean diameter around 1000 μm. The surface roughness of the particles varied according to the polymer type. Chitosan only particles have a comparatively smooth surface (Fig. 3IA & B) to alginate only MPs which have a rough surface with a large number of cracks ( Fig. 3IIA & B) . Chitosan-alginate particles show very high surface roughness with a large number ofsurfaceirregularities, and further, no cracks are visible on the surface (Fig. 3IIIA & B, IVA & B) . Similarly, lyophilized MPs also have high surface roughness with pore structure (Fig. 3VA & B) . The appearance of the cross section areas of all the samples, except the lyophilized sample (Fig. 3VC) shows no pores and perforations. The surface roughness is an important feature related to cell adhesion and proliferation. It was reported that cells like to attach and proliferate more on a uniformly rough surface rather than a surface with random pattern and discontinuation (Gaihre and Jayasuriya, 2016) . According to the SEM micrographs shown in Fig. 3 , it can be seen that which facilitates good cell adhesion and proliferation.
FTIR Spectrum analysis
FTIR spectra were adopted to characterize the potential interactions in the MPs. FTIR spectra of chitosan, alginate, vancomycin, and vancomycin loaded with chitosan, alginate, and chitosan-alginate mixed MPs are shown in Fig. 4 . All the characteristic peaks are visible in the spectra Li et al., 2008) . The following are important characteristic peaks for Vancomycin: at 1230 cm − 1 , corresponding to , corresponding to the vibration of CeN. These peaks are not clearly visible in the spectra since all the characteristic peaks of chitosan and alginate are also in that region. However, peak shifts and the broadening of the peaks can be visible, as marked on the FTIR spectra. Fig. 4 demonstrates the presence of vancomycin in the MPs. Fig. 5 illustrates the swelling behavior of MPs in PBS. As shown in Fig. 5 , alginate MPs exhibited significantly high swelling ratios compared to the other MPs. After day 1, no significant increase in the swelling ratio was observed. Chitosan showed the least swelling ratio while chitosan-alginate mixed MPs exhibited slightly higher swelling ratios, increased with increasing alginate concentration. However, the swelling ratio difference between CS-1%AL and CS-2%AL was not significant. Lyophilized MPs also have a higher swelling ratio with a significance difference to all the groups, because of their porous structure, which absorbs more water.
Swelling studies
Hydration of the hydrophilic groups in both chitosan and alginate attributed to the swelling of the MPs. Amino groups in chitosan and carboxylate groups in alginate play a major role in swelling. In contrast to the carboxylate group in alginate, the remaining free amino groups lessened after ionic crosslinking, are not protonated at neutral pH (7.4). Therefore, the swelling of chitosan MPs is significantly lower than alginate MPs. When carboxylate groups are protonated, the particles tend to absorb water to fill the void regions in the polymer network, until equilibrium is achieved. This process also provokes the relaxation of the polymer network under osmotic pressure. Equilibrium swelling is achieved when osmotic pressure equals to the bond strength of crosslinking polymer network (Pasparakis and Bouropoulos, 2006) . The change in swelling ratio after day 1 is mainly due to the change of PBS which disturbs the equilibrium condition between MPs and solution. The low swelling ratio of chitosan-alginate mixed particles is due to two main factors: mixing of chitosan and alginate form a more entangled system and amino groups in chitosan and carboxylate groups in alginate make a polyelectrolyte complex, which is denser and increases the resistance to osmotic pressure (Lin et al., 2005) . Fig. 6 shows cumulative vancomycin release percentage curves of the five types of MPs at 37 ± 0.5°C as a function of time. The release of the vancomycin from alginate alone MPs was significantly high. At day 1, nearly 28% of the encapsulated drug was released and at day 6, 86% of the encapsulated drug was released. In contrast, the slowest release was observed from the chitosan only MPs. At day 21, only 25% of vancomycin release was observed from the MPs. However, all the chitosan-alginate MPs showed moderate release as expected. The best release was obtained from CS-1%AL lyophilized sample, and nearly 78% of the drug was released within 21 days. CS-1%AL air-dried sample released 50% of the encapsulated drug. So, the porosity of the lyophilized sample influences the vancomycin release compared to the nonporous air-dried CS-AL MPs. Higher alginate concentrations did not increase the drug release from MPs, as it was clearly seen in the results of CS-2%AL sample (nearly 40% release at day 21). According to the results, best vancomycin release was observed in CS-1%AL lyophilized MPs as it releases nearly 80% of encapsulated drug within a three week period. Apart from the burst release of day 1, CS-1%AL MPs release an average of 22 μg per day of vancomycin, up to 14 days. Even though CS-1%AL MP shows good drug release, only 50% of the encapsulated drug was released in first three weeks. The results suggested that lyophilized chitosan-alginate MPs could hold the drug better at 7.4 pH and facilitate controlled release of vancomycin up to 3 weeks. According to the results, AL shows higher release rate of the drug or burst release during day 1. Burst release is often considered as a negative effect when considering the long term drug delivery system. This burst release effect leads to negative consequences such as local toxicity from high drug concentration, requires more frequent dosing, and are economically and therapeutically wasteful of the drug. Burst release has been associated with different physical, chemical, and processing parameters (Huang and Brazel, 2001 ). Migration of the drug during the drying process creates heterogeneous drug distribution and it facilitates the burst release. Also, the formation of surface cracks leads to the burst release as it facilitates surface erosion of the MPs (Kim and Lee, 1992; Park et al., 1992) . It can be clearly seen that complexation of chitosan with alginate reduces the burst release behavior of alginate MPs. This reduction is due to the decrease of void spaces in the alginate polymer network. Low void spaces in the polymer network reduces the swelling of the MPs, and hence prevents burst release (George and Abraham, 2006) .
Cumulative drug release in-vitro and release kinetics of vancomycin
The encapsulation efficiency (EE%) and loading degree (LD%) are also considered as important parameters when we consider the good drug delivery system. The EE% and LD% data are shown in the Table 1 . The lower EE% is mainly due to the lower MW of chitosan and solubility of the vancomycin hydrochloride: vancomycin is highly soluble in water. The MW of the chitosan plays an important role in drug entrapment, chitosan with high MW shows higher amount drug or protein entrapment due to their longer chains (Puri et al., 2008; Xu and Du, 2003) . In contrast, release of the drug reduces with the increasing MW as it entrap more drugs with their longer polymer chains. In targeted drug delivery system, slow and prolonged delivery is not suitable. Further, degradation rate also increases with the increasing MW (Hsu et al., 2004) . Charge is another parameter that can affects to the encapsulation efficiency. Vancomycin is positively charged at the physiological pH (around 7.4) and also it has multitude of pKa values distributing a large pH range (Shah et al., 2014; Vijan, 2009) . Chitosan is also a positively charge polymer at a weak acidic environment. Therefore, when the particle droplets are added to the TPP aqueous solution, vancomycin can be easily diffused to the TPP solution, due to their positive-positive drug polymer repulsive forces. Low MW of chitosan further facilitates this mechanism. However, alginate MPs have higher encapsulation efficiency compared to the chitosan contain MPs, since it is negatively charge at 7.4 pH value. Because of the multitude pKa values, the presence of negative charges in vancomycin reduces the negative-positive interaction between polymer and drug (Shah et al., 2014) . In this study, low MW chitosan contain MPs show higher amount of drug release within 3 week period. The average daily vancomycin release from lyophilized sample is greater than the minimal inhibitory content (MIC) of vancomycin for bacteria like S. epidermidis. The MIC of vancomycin is around 8-16 μg/ml (Mantripragada and Jayasuriya, 2016) . In this study, low MW chitosan was used due to their high degradation rate and higher release rate of drug compared to the medium and high MW chitosan. Further process optimizations are required to increase the encapsulation efficiency of the vancomycin. Number of authors also reported low EE% and LD% values for chitosan or biodegradable polymer based drug delivery systems, such as ampicillin release of chitosan-alginate beads (Anal and Stevens, 2005) , protein delivery of chitosan nanoparticles (Xu and Du, 2003) , tetracycline release from polyhydroxybutyrate-co-hydroxyvalerate biodegradable MPs (Sendil et al., 1999) , and ketoprofen encapsulation to the chitosan MPs (Genta et al., 1998) . The particle sizes of the MPs are suitable for parenteral delivery using 16 or lower gauge needles. Also, these particles can be injected to the bone defects during the open surgery. These MPs not only release the antibiotics but also provide the better mechanical stability to the bone defects.
The main objective of this research work was to understand the release kinetics and transport mechanisms involved in the vancomycin release from the chitosan-alginate microparticles. Five different models were used to fit the experimental data using Origin Pro 9 software. The model parameters were calculated using the nonlinear least square regression method and the RSS and AIC values were calculated for each model as they provide the suitability of the model for the given experimental data set. The smaller RSS and AIC values indicate a better fit of experimental data into the model. Results of the model parameters, RSS values, and AIC values are given in Tables 2-7. All of the kinetics models are valid, only for the first 60% of drug release (Costa and Lobo, 2001 ). So, AL MPs and CS-1%AL LP MPs release were taken up to initial 60% of the drug release. Since the AIC values depend on the number of data points in the fitted curve, AIC value of AL only (10 data points) and CS-1%AL LP (16 data points) MPs cannot be compared with the other three sets of MP's AIC values (23 data points). Table 6 is used to find the best fit model of the experimental data for each sample type by comparing AIC values. Table 2 shows the diffusional exponent (n) and release constant (k) for vancomycin release from MPs. All the MPs, except the lyophilized MPs, show n values around 0.30 ± 0.01. According to Ritger and Peppas, when n = 0.43 the drug release mechanism is governed by the Fickian diffusion, when 0.43 < n < 0.85 it is anomalous (non-Fickian) transport, and when n = 0.85 it is case II transport Peppas, 1987a, 1987b) . These values are true for the monodispersed polymer samples, but here polydispersed MPs have been used. In polydispersed MPs, Fickian diffusion mechanism can be distinguished by n values < 0.43. Ritger and Peppas mentioned that n values around 0.3 ± 0.1 are also possible for Fickain diffusion in polydisperse spherical samples (Ritger and Peppas, 1987b) . However, the lyophilized sample shows n ≈ 0.5, which attributed to anomalous (non-Fickian) transport. So, porosity of the MPs play a major role in the drug transport mechanism. Fig. 7 shows the non-linear curve fitting to the experimental data using Ritger-Peppas model. Further, release constant (k) is directly proportional to the diffusion constant and hence depends on the physical and structural properties of both the drug and polymer matrix. This k value indicates the release rate of the drug (Gbureck et al., 2008) . As shown in Table 2 , the highest k value was obtained from AL MPs which has a higher release rate and lowest k value from the CS MPs. Table 3 and Fig. 8 show the Higuchi model experimental data analysis. Theoretically, Higuchi model cannot be used to analyze swellable drug delivery systems. However, due to the extreme simplicity of the model, it has been widely used in swellable polymer systems (Carbinatto et al., 2014; Serra et al., 2006; Yan et al., 2017) to get some idea of the drug transport mechanism. Proportionality between the cumulative drug release and the square root of time is considered as a good indicator in a diffusion controlled drug delivery system (Siepmann and Peppas, 2001) .Therefore, additional mathematical analysis must be needed to conclude if the Higuchi model is used. The difference between the Ritger-Peppas model and Higuchi model is the exponent n. Since Higuchi model assumes n = 0.5, vancomycin release from lyophilized MPs is best fitted to that as 0.5 is very close to the n value obtained from Ritger-Peppas model in Table 2 (n = 0.496). All other four types of MPs do not fit well with the Higuchi model as shown in Table 3 and Fig. 8 . Table 4 and Fig. 9 relate to the Peppas-Sahlin model.
According to Table 7 , the best fit model to the experimental data is Peppas-Sahlin model except for AL only MPs. Both Fickian contribution (first term of Eq. (4)) and the case II relaxation contribution (second (4)) are considered in this model. The exponential coefficient m relates to the purely Fickian diffusion exponent. If the relaxational mechanism is negligible, the value of n in Eq. (4) and value of m in Eq. (6) should be equal. So, the difference in n and m exponents suggests that the vancomycin release mechanism from MPs not only depends on the Fickian diffusion but also on case II relaxation. The percentage of drug release from Fickian diffusion, F, can be calculated as follows;
From the above expression, ratio of relaxational over Fickian contribution can be calculated by (Peppas and Sahlin, 1989) 
R/F ratio (Eq. (11)) was calculated by using the parameters given in Table 4 . R/F ratio vs. time graph is shown in the Fig. 12 . The initial drug release from the MPs are controlled by the Fickian diffusion as it indicated by the very low R/F values. Increasing R/F ratio values with time indicate the increasing relaxational contribution. When R/F = 1, the release mechanism contains both erosion and diffusion equally. If R/F > 1, the relaxation (erosion) dominates, while for R/F < 1, diffusion dominates. Peppas-Sahlin model also shows the higher release rate values (k 1 and k 2 ) for AL only MPs, similar to the Ritger-Peppas and Higuchi models. This further confirms the significantly higher release of vancomycin in AL only MPs. As shown in Fig. 12 , relaxational contribution is also higher in AL MPs compared to the all other air-dried MPs. CS only, CS-1%AL, and CS-2%AL air-dried MPs show almost similar R/F ratios in the beginning and slightly increases with the increasing AL content in later parts. Highest relaxational contribution is observed in CS-AL lyophilized MPs as shown in the Fig. 12 . After day 10, R/F ratio is > 1, which indicates the domination of relaxation contribution. Zero order model assumes case II transport (Fig. 10) . The larger RSS values shown in Table 5 and AIC values shown in Table 7 indicate poor fitting of experimental data. So, vancomycin release from MPs is not completely driven by case II transport. First order model also does not fit well with the experimental data as shown in Table 6 and Fig. 11 . Both zero order and first order models reflect reservoir type drug delivery system. In summary, drug transport mechanisms and release amount of vacomycin greatly depend on the physicochemical characteristics of the MPs. All the air dried MPs showed Fickian diffusion driven drug transport mechanism and lyophilized MPs showed anomolous transport. The higher release rate from the alginate was mainly due to the high swelling ratio as it increases the porosity of the polymer matrix and faclitates the diffusion of the drug. Slowest release in the CS MPs was attributted to the strong crosslinking of the polymer marix and it prevents the release of entrapped drug. Adding alginate increases the release rate compared to chitosan only MPs and decreases the release rate compared to alginate only MPs as it combines the both chitosan and alginate properties. Addition of more alginate increases the complexation between chitosan and alginate and it reduces the release rate of the vancomycin. Porosity significantly effects to the drug transport mechanism and release rate. Eventhough lyophilizing method reduces the encapsulation efficiency of the vancomycin compared with air dried MPs as shown in Table 1 , percentage of drug release significantly increases compared to the air-dried chitosan-alginate MPs. So, lyopholized chitosan-alginate MPs can be successfully used as a controlled vancomycin delivery system for bone injuries.
Conclusions
Chitosan-alginate polyelectrolyte MPs were synthesized to be used as a controlled drug release device by combining release properties of both alginate and chitosan. Chitosan-alginate complexes show rough and uniform surface morphology which may act as a catalyst for cell adhesion and proliferation. The best release was obtained from the CS-1%AL lyophilized MPs. Increasing alginate concentration reduces the vancomycin release rate. Peppas-Sahlin model was the best fit kinetic model for all the MPs. The vancomycin released mechanism from all the air dried MPs (CS only, AL only, CS-1%AL, and CS-2%AL) are dominated by Fickian diffusion, but the case II relaxational component gradually increases with time. For CS-1%AL LP MPs, case II relaxation dominates after day 10 which indicates more anomalous transport as suggested by Ritger-Peppas model. The porosity of the MPs significantly effects the drug transport mechanisms, as lyophilized MPs show anomalous transport, and air-dried MPs show Fickian diffusion dominated transport. 
